Treatment Approach with Hydoxyurea

Laura C. Michaelis, MD

Video Categories: Polycythemia Vera

Laura C. Michaelis, MD, Medical College of Wisconsin describes the approach of treating polycythemia vera with hydoxyurea.

Supported through funding from Incyte
March 31, 2015

Blending Treatments Worldwide for Multiple Myeloma

David S. Siegel, MD, PhD, at the John Theurer Cancer Center in Hackensack, NJ, explains the benefits of worldwide clinical trials in creating more consistent, less toxic treatment options for multiple myeloma. New drugs are coming along, and the clinical trials for those drugs are beginning to mature.

December 3, 2013

The Impact of Hedgehog Pathway Inhibitors on the Management of Patients with Basal Cell Carcinoma

In this third WCMC clinical commentary entitled, Basal Cell Carcinoma Case Studies in Hedgehog Pathway Inhibition Radiation, Joel Claveau, MD, CSPQ, FRCPC; Dirk Schadendorf, MD; Nicole Basset-Seguin, MD, PhD and Aleksandar Sekulic, MD, PhD discuss different case studies where patients were successfully treated by Hedgehog Pathway Inhibitors.